MedPage Today on MSN
FDA Approves Generic Flovent Inhaler for Asthma
Move comes 2 years after controversial exit of brand-name product ...
MONTRÉAL-- (BUSINESS WIRE)--Teva Canada, a subsidiary of Teva Pharmaceutical Industries Ltd., today announced product availability of Aermony RespiClick™, indicated for the maintenance treatment of ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
In asthma, the combination is indicated for adults and kids ages 6 and older to prevent symptoms (not for acute attacks); in COPD, the inhaler is approved as a maintenance treatment to improve ...
Bronchial hyperresponsiveness may indicate the presence of cough-variant asthma in nonsmokers who have chronic cough, new research shows. This research shows that sensitivity in the bronchial tubes—a ...
Children with mild asthma may use two inhalers – one steroid and the other a bronchodilator, when symptoms occur, a new study shows. A team of researchers at the Washington University School of ...
With the quality of air steadily decreasing in large cities, and in the high-AQI regions particularly, respiratory complaints have increased exponentially.Chronic coughing, wheezing, chest tightness ...
Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and affects 3.8 million Canadians.1–3 Although inhaled medication is the cornerstone of therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results